Godrej Agrovet Limited - FY2026 Comprehensive Performance Overview
Reporting Period: Financial Year 2025-26
Financial Performance Highlights
Godrej Agrovet delivered strong financial results for FY2026 with consolidated revenue reaching ₹10,233 crore, representing 9.1% growth year-over-year. Net profit stood at ₹445 crore with basic EPS of ₹24.58. The company reported standalone revenue of ₹7,744 crore with net profit of ₹526 crore. All six business segments showed positive performance, led by Animal Nutrition (48.3% of revenue) and Vegetable Oil (19.6% of revenue).
35th Annual General Meeting Outcomes
The 35th AGM held on August 5, 2026, approved all six resolutions with overwhelming majority, including:
- Adoption of audited financial statements for FY2025-26
- Declaration of 110% final dividend (₹11 per share)
- Re-appointment of Nisaba Godrej and Pirojsha Godrej as directors
- Ratification of cost auditors' remuneration
- Approval of Burjis Godrej's remuneration as Chairperson & Executive Director
The final dividend was paid on August 10, 2026, to shareholders of record as of July 29, 2026.
Strategic Acquisitions and Investments
The company completed significant acquisitions during FY2026:
- Increased stake in Creamline Dairy Products Limited to 99.78% from 62.53% through investments totaling ₹717.51 crore
- Became 100% owner of Godrej Foods Limited
- Participated in Astec LifeSciences' rights issue, investing ₹199.01 crore to increase holding to 67.03%
- Recognized ₹32.96 crore impairment on Godrej Cattle Genetics due to carrying value exceeding recoverable amount
Management and Governance Changes
Major leadership transitions occurred during the year:
- Sunil Kataria appointed as CEO & Managing Director effective September 1, 2025, with total remuneration of ₹9.70 crore
- Balram Singh Yadav stepped down as Managing Director on August 31, 2025, receiving ₹8.40 crore remuneration
- Natarajan Srinivasan resigned as Independent Director due to potential conflict of interest
- Multiple committee composition changes across Audit, Risk Management, CSR, and Stakeholders' Relationship committees
Financial Position and Capital Structure
Total assets stood at ₹5,810 crore with borrowings of ₹1,468 crore and maintained a healthy debt-equity ratio of 0.16 times. Cash and cash equivalents were ₹299 crore. The company recognized an exceptional item of ₹30.44 crore relating to Labour Code implementation impacts on gratuity and leave encashment benefits.
Sustainability and ESG Performance
Godrej Agrovet demonstrated strong sustainability achievements:
- 78% renewable energy consumption (targeting 90%)
- Water positive status (conserving 14x more water than consumed)
- 29,750 MT of CO₂ sequestered in FY2026
- 12% reduction in Scope 1 and Scope 2 greenhouse gas emissions
- "A-" leadership band rating from CDP for Climate and Forest disclosures
- CSR initiatives impacted over 14,000 dairy farmer households
Regulatory Compliance and Reporting
The company fulfilled all SEBI Listing Regulations requirements, submitting:
- Corporate Governance Report
- Business Responsibility & Sustainability Report (BRSR) with limited assurance on core parameters
- Audited standalone and consolidated financial statements
- AGM outcome disclosures and voting results
All documents were prepared in accordance with Regulation 34 of SEBI Listing Regulations and relevant sections of the Companies Act, 2013, with B S R & Co. LLP serving as statutory auditors.
Segment Performance Breakdown
- Animal Nutrition: Robust performance with 19% YoY profitability growth and 12% volume growth
- Oil Palm Business: Standout performer with 68% YoY growth in segment profitability
- Crop Care Business: Expanded into new crop segments (maize and paddy) despite challenging environment
- Dairy Business: Faced headwinds from elevated milk procurement costs but focused on operational efficiencies
- Astec LifeSciences: Achieved EBITDA break-even with improved volumes and capacity utilization